Meyer D - Search Results

1

von Willebrand factor and platelet function.

Baruch D, Bahnak B, Girma JP, Meyer D. Baruch D, et al. Among authors: meyer d. Baillieres Clin Haematol. 1989 Jul;2(3):627-72. doi: 10.1016/s0950-3536(89)80037-x. Baillieres Clin Haematol. 1989. PMID: 2673431 Review.

2

von Willebrand factor: structure and function.

Meyer D, Piétu G, Fressinaud E, Girma JP. Meyer D, et al. Mayo Clin Proc. 1991 May;66(5):516-23. doi: 10.1016/s0025-6196(12)62394-5. Mayo Clin Proc. 1991. PMID: 1903172 Review.

3

A monoclonal antibody (B724) to von Willebrand factor recognizing an epitope within the A1 disulphide loop (Cys509-Cys695) discriminates between type 2A and type 2B von Willebrand disease.

Christophe O, Rouault C, Obert B, Piétu G, Meyer D, Girma JP. Christophe O, et al. Among authors: meyer d. Br J Haematol. 1995 May;90(1):195-203. doi: 10.1111/j.1365-2141.1995.tb03400.x. Br J Haematol. 1995. PMID: 7540413 Clinical Trial.

4

Fluid-phase immunoradiometric assay for the detection of qualitative abnormalities of factor VIII/von Willebrand factor in variants of von Willebrand's disease.

Girma JP, Ardaillou N, Meyer D, Lavergne JM, Larrieu MJ. Girma JP, et al. Among authors: meyer d. J Lab Clin Med. 1979 Jun;93(6):926-39. J Lab Clin Med. 1979. PMID: 312307

5

Aurin tricarboxylic acid inhibits platelet adhesion to collagen by binding to the 509-695 disulphide loop of von Willebrand factor and competing with glycoprotein Ib.

Girma JP, Fressinaud E, Christophe O, Rouault C, Obert B, Takahashi Y, Meyer D. Girma JP, et al. Among authors: meyer d. Thromb Haemost. 1992 Dec 7;68(6):707-13. Thromb Haemost. 1992. PMID: 1287886

6

Comparison of the primary structure of the functional domains of human and porcine von Willebrand factor that mediate platelet adhesion.

Bahnak BR, Lavergne JM, Ferreira V, Kerbiriou-Nabias D, Meyer D. Bahnak BR, et al. Among authors: meyer d. Biochem Biophys Res Commun. 1992 Jan 31;182(2):561-8. doi: 10.1016/0006-291x(92)91769-m. Biochem Biophys Res Commun. 1992. PMID: 1370885

7

Defects in type IIA von Willebrand disease: a cysteine 509 to arginine substitution in the mature von Willebrand factor disrupts a disulphide loop involved in the interaction with platelet glycoprotein Ib-IX.

Lavergne JM, De Paillette L, Bahnak BR, Ribba AS, Fressinaud E, Meyer D, Pietu G. Lavergne JM, et al. Among authors: meyer d. Br J Haematol. 1992 Sep;82(1):66-72. doi: 10.1111/j.1365-2141.1992.tb04595.x. Br J Haematol. 1992. PMID: 1419804

8

Molecular study of von Willebrand disease: identification of potential mutations in patients with type IIA and type IIB.

Piétu G, Ribba AS, de Paillette L, Chérel G, Lavergne JM, Bahnak BR, Meyer D. Piétu G, et al. Among authors: meyer d. Blood Coagul Fibrinolysis. 1992 Aug;3(4):415-21. Blood Coagul Fibrinolysis. 1992. PMID: 1420817

9

Evidence that a secondary binding and protecting site for factor VIII on von Willebrand factor is highly unlikely.

Layet S, Girma JP, Obert B, Peynaud-Debayle E, Bihoreau N, Meyer D. Layet S, et al. Among authors: meyer d. Biochem J. 1992 Feb 15;282 ( Pt 1)(Pt 1):129-37. doi: 10.1042/bj2820129. Biochem J. 1992. PMID: 1531749 Free PMC article.

10

Ristocetin and botrocetin involve two distinct domains of von Willebrand factor for binding to platelet membrane glycoprotein Ib.

Girma JP, Takahashi Y, Yoshioka A, Diaz J, Meyer D. Girma JP, et al. Among authors: meyer d. Thromb Haemost. 1990 Oct 22;64(2):326-32. Thromb Haemost. 1990. PMID: 1702906

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,536 results

Search Page

Filters